Skip to main content

What the FDA labels say about taking them together

Elagolix and midazolam

Elagolix's FDA label of December 19, 2025 names midazolam in its drug interactions section; the midazolam labels PlainMeds reads (4) do not name elagolix. The elagolix label: “Consider increasing the dose of midazolam by no more than 2-fold and individualize midazolam therapy based on the patient’s response.”

Check it at the source: the elagolix FDA label on DailyMed (effective December 19, 2025, AbbVie Inc.); the midazolam FDA label on DailyMed (effective January 1, 2024, Fresenius Kabi USA, LLC).

What does the elagolix label say about midazolam?

Elagolix label, drug interactions

Concomitant Drug Class/Drug Name: Benzodiazepines: oral midazolam; Effect on Plasma Exposure of Concomitant Drug: ↓ midazolam; Clinical Recommendations: Consider increasing the dose of midazolam by no more than 2-fold and individualize midazolam therapy based on the patient’s response.

Source: FDA drug label (Orilissa), AbbVie Inc., effective December 19, 2025 (SPL set a86757b3-09c5-fd3b-1223-244e94f50a66), via openFDA; the full label on DailyMed

What does the midazolam label say about elagolix?

Midazolam's label (effective January 1, 2024) and its 3 other brand-application labels do not name elagolix in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Midazolam), Fresenius Kabi USA, LLC, effective January 1, 2024 (SPL set 1cc9ba6e-fa1b-405e-9de8-720c567b2a73), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Elagolix generic labelers
22Midazolam generic labelers
ElagolixMidazolam
Labeled forn/an/a
Boxed warningNoYes
Pharmacy cost (NADAC)$43.81 per tablet 150 mg tablet$0.233 per mL 2 mg/2 mL vial
Shortage nowNo current entryIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?